The Reagan-Udall Foundation for the FDA’s meeting on Considerations for Buprenorphine Initiation and Maintenance Care explored real-world experiences and scientific evidence for initiation of buprenorphine, as well as medication dosing and management during continued treatment across different care settings. This report summarizes the presentations and panel discussions from the meeting.
- About
- Projects
- Column 1
- Advancing Regulatory Science
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
- Column 2
- Food & Nutrition
- Improving Access to FDA Information
- Research
- Substance Use Disorders
- Column 1
- News and Events
- Expanded Access eRequest